Susan E. Graf's most recent trade in Aardvark Therapeutics Inc. was a trade of 30,508 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics Inc. | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 30,508 | 30,508 | - | - | Stock Option (right to buy) | |
| Cg Oncology Inc. | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 24,165 | 24,165 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Finch Therapeutics Group Inc | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 44,843 | 44,843 | - | - | Stock Option (right to buy) | |
| Finch Therapeutics Group Inc | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 23,419 | 23,419 | - | - | Stock Option (right to buy) |